pharma news today glp-1 obesity drugs 💊 The next trillion-dollar drug war has begun Drugmakers including Eli Lilly, Novo Nordisk, Pfizer, Amgen, AstraZeneca and others are racing beyond today's drugs. New pills, monthly injections and next-generation India's fast-growing weight-loss drug market

Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression

Warning signs that should prompt immediate medical attention include: New or worsening depression, anxiety, or mood swings Thoughts of self-harm or suicide Significant changes in sleep patterns or energy levels Social withdrawal or loss of interest in previously enjoyed activities Increased irritability, agitation, or restlessness Feelings of hopelessness or worthlessness Difficulty concentrating or making decisions Clinicians should establish baseline mental health status before initiating therapy and conduct regular assessments during treatment, consistent with American Diabetes Association Standards of Care recommendations for psychosocial assessment

Instead, they often contain vitamins or herbs, such as berberine, green tea extract, or Garcinia Cambogia, but there is no scientific evidence that shows these patches work for weight loss

Zhao L, Zhu C, Lu M, et al

134979-01-4, CH2COOH-PEG2-NH2.HCl CAS NO.1662688-20-1, Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH CAS NO.1143516-05-5, 17-amino-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecan-1-oic acid CAS NO.871-70-5, Octadecanedioic acid Liraglutide intermediates: CAS NO.204521-63-1, Pal-L-Gljavascript:void(0)-OtBu CAS NO.1491158-62-3, Fmoc-Lys(Pal-Glu-OtBu)-OH CAS NO.294855-91-7, Pal-Gljavascript:void(0)-OH CAS NO.536721-25-2, (S)-5-(tert-butoxy)-5-oxo-4-palmitamidopentanoic acid References: [1]

Among the 534 cases of suicidal and self-injurious behavior associated with GLP-1RA in our study, 275 (51.50%) cases experienced suicidal ideation